AEON Biopharma AEON Income Statement (2020-2026)

NYSE AEON
$0.20 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating items
Research & Development (Quarter)
7.48M9.53M9.21M9.03M6.39M5.73M4.44M0.97M3.04M0.82M1.06M0.60M1.61M2.94M
Selling, General & Administrative (Quarter)
2.44M5.50M3.84M4.95M5.26M4.65M3.32M3.04M2.63M3.12M3.26M1.93M3.89M2.99M
Other Operating Expenses (Quarter)
0.40M0.45M0.89M0.39M0.43M272.06M63.77M-161.23M-3.35M-3.49M0.02M-0.04M0.01M-0.01M
Operating Expenses (Quarter)
0.40M0.45M0.89M0.39M0.43M9.91M15.03M13.05M13.97M283.71M74.15M-153.47M4.02M2.32M0.46M4.34M2.49M5.51M5.92M
Operating Income (Quarter)
-0.40M-0.45M-0.89M-0.39M-0.43M-9.91M-15.03M-13.05M-13.97M-283.71M-74.15M153.47M-4.02M-2.32M-0.46M-4.34M-2.49M-5.51M-5.92M
EBIT (Quarter)
-0.40M-0.45M-0.89M-0.39M-0.43M-9.91M-15.03M-13.05M-13.97M-283.71M-74.15M153.47M-4.02M-2.32M-0.46M-4.34M-2.49M-5.51M-5.92M
Non-operating items
Interest & Investment Income (Quarter)
0.03M0.02M0.02M0.13M0.14M1.15M2.29M1.70M0.20M
Other Non Operating Income (Quarter)
-3.66M6.09M1.11M3.03M2.17M0.14M0.15M0.06M0.04M0.19M0.04M0.03M0.02M0.00M0.10M0.09M0.07M-0.17M0.04M
Non Operating Income (Quarter)
-3.63M6.11M1.13M3.16M2.31M-0.53M-19.53M-4.59M-1.41M-14.00M-43.87M10.64M-2.15M4.40M9.56M-2.30M-2.04M-31.63M4.76M
Net income details
EBT (Quarter)
-4.03M5.66M0.25M2.77M1.88M-10.44M-34.56M-17.64M-15.38M-297.71M-118.02M164.11M-6.17M2.08M9.10M-6.64M-4.54M-37.14M-1.16M
Tax Provisions (Quarter)
0.02M0.40M0.09M-0.50M
Profit After Tax (Quarter)
-4.03M5.66M0.25M2.77M1.87M1.64M0.09M-0.39M-3.94M-297.71M-118.02M164.11M-6.17M2.08M9.10M-6.64M-4.54M-37.14M-1.16M
Income from Continuing Operations (Quarter)
-4.03M5.66M0.25M2.77M1.87M-10.44M-34.56M-18.04M-15.47M-297.71M-118.02M164.11M-6.17M2.58M9.10M-6.64M-4.54M-37.14M-1.16M
Consolidated Net Income (Quarter)
-4.03M5.66M0.25M2.77M1.87M-10.44M-34.56M-18.04M-15.47M-297.71M-118.02M164.11M-6.17M2.58M9.10M-6.64M-4.54M-37.14M-1.16M
Income towards Parent Company (Quarter)
-4.03M5.66M0.25M2.77M1.87M-10.44M-34.56M-18.04M-15.47M-297.71M-118.02M164.11M-6.17M2.58M9.10M-6.64M-4.54M-37.14M-1.16M
Net Income towards Common Stockholders (Quarter)
-3.22M4.53M4.59M2.22M1.49M0.33M0.02M-0.25M-0.89M-297.71M-118.02M164.11M-6.17M2.58M9.10M-6.64M-4.54M-37.14M-1.16M
Additional items
EPS (Basic) (Quarter)
-33.6011.8113.485.793.900.860.05-1.40-9.25-576.79-227.99304.17-11.244.772.28-0.60-0.39-3.74-0.12
EPS (Diluted) (Quarter)
-8.4011.8113.485.793.900.860.05-1.40-9.25-576.79-227.99304.17-11.244.482.28-0.60-0.39-3.74-0.12
Shares Outstanding (Quarter)
0.10M0.38M0.34M0.38M0.38M0.38M0.38M0.18M0.10M0.52M0.54M0.52M0.54M0.55M0.54M3.98M11.09M11.63M9.92M9.92M
Shares Outstanding (Diluted) (Quarter)
0.38M0.38M0.34M0.38M0.38M0.38M0.38M0.18M0.10M0.52M0.52M0.52M0.54M0.55M0.58M3.98M11.09M11.63M9.92M9.92M
Shares Outstanding (Entity) (Quarter)
0.10M0.38M0.34M0.38M0.38M0.38M0.38M0.18M0.10M0.52M0.52M0.53M0.54M0.55M0.56M3.98M11.54M11.64M9.92M50.53M
EBITDA (Quarter)
-0.40M-0.45M-0.89M-0.39M-0.43M-9.91M-15.03M-13.05M-13.97M-283.71M-74.15M153.47M-4.02M-2.32M-0.46M-4.34M-2.49M-5.51M-5.92M
Interest Expenses (Quarter)
0.39M0.07M0.07M0.08M0.08M0.37M53.98M0.21M1.58M0.31M0.08M0.32M0.32M1.32M0.07M1.10M
Tax Rate (Quarter)
0.90%-2.29%-0.60%-23.84%